Zolpidem (Serbo-Croatian Wikipedia)

Ambien.com (2004). „AMBIEN Prescribing Information”. Information About a Short-term Treatment for Insomnia - Ambien.com Home Page for Health-care Professionals. Sanofi-Synthelabo Inc. New York, NY 10016. Arhivirano iz originala na datum 2005-06-27. Pristupljeno 27. 06. 2005.

archive.org

Patat A; Naef MM, van Gessel E, Forster A, Dubruc C, Rosenzweig P (October 1994). „Flumazenil antagonizes the central effects of zolpidem, an imidazopyridine hypnotic”. Clin Pharmacol Ther 56 (4): 430–6. PMID 7955804.
Wesensten NJ; Balkin TJ, Davis HQ, Belenky GL (September 1995). „Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil”. Psychopharmacology (Berl) 121 (2): 242–9. DOI:10.1007/BF02245635. PMID 8545530.
Brefel-Courbon C, Payoux P, Ory F, Sommet A, Slaoui T, Raboyeau G, Lemesle B, Puel M, Montastruc JL, Demonet JF, Cardebat D (July 2007). „Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy”. Ann. Neurol. 62 (1): 102–5. DOI:10.1002/ana.21110. PMID 17357126.
Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T (2004). „Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis”. Human psychopharmacology 19 (5): 305–22. DOI:10.1002/hup.594. PMID 15252823.

aspetjournals.org

molpharm.aspetjournals.org

Smith, AJ.; Alder, L.; Silk, J.; Adkins, C.; Fletcher, AE.; Scales, T.; Kerby, J.; Marshall, G. i dr.. (May 2001). „Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux.” (PDF). Mol Pharmacol 59 (5): 1108–18. PMID 11306694.
Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, Whiting PJ (1996). „Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit”. Mol. Pharmacol. 50 (3): 670–8. PMID 8794909. Arhivirano iz originala na datum 2009-01-08. Pristupljeno 2010-10-24.

jpet.aspetjournals.org

Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G (1986). „Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects”. J. Pharmacol. Exp. Ther. 237 (2): 649–58. PMID 2871178.

bbc.co.uk

news.bbc.co.uk

„Pill 'reverses' vegetative state”. BBC. 23. 05. 2006.. Pristupljeno 20. 11. 2006.
"Pill 'reverses' vegetative state" BBC News, 23 May 2006, retrieved 20 June 2007.

doi.org

dx.doi.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
Lemmer B (2007). „The sleep-wake cycle and sleeping pills”. Physiol. Behav. 90 (2-3): 285–93. DOI:10.1016/j.physbeh.2006.09.006. PMID 17049955.
Rosenberg, RP. (Jan 2006). „Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.”. Ann Clin Psychiatry 18 (1): 49–56. DOI:10.1080/10401230500464711. PMID 16517453.
Wesensten NJ; Balkin TJ, Davis HQ, Belenky GL (September 1995). „Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil”. Psychopharmacology (Berl) 121 (2): 242–9. DOI:10.1007/BF02245635. PMID 8545530.
Brefel-Courbon C, Payoux P, Ory F, Sommet A, Slaoui T, Raboyeau G, Lemesle B, Puel M, Montastruc JL, Demonet JF, Cardebat D (July 2007). „Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy”. Ann. Neurol. 62 (1): 102–5. DOI:10.1002/ana.21110. PMID 17357126.
Evidente VG, Caviness JN, Adler CH (2003). „Case studies in movement disorders”. Seminars in neurology 23 (3): 277–84. DOI:10.1055/s-2003-814739. PMID 14722823.
Salvà P, Costa J (September 1995). „Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications”. Clin Pharmacokinet 29 (3): 142–53. DOI:10.2165/00003088-199529030-00002. PMID 8521677.
Pritchett DB, Seeburg PH (1990). „Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology”. J. Neurochem. 54 (5): 1802–4. DOI:10.1111/j.1471-4159.1990.tb01237.x. PMID 2157817.
Rowlett JK, Woolverton WL (November 1996). „Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies”. Psychopharmacology (Berl.) 128 (1): 1–16. DOI:10.1007/s002130050103. PMID 8944400.
Noguchi H, Kitazumi K, Mori M, Shiba T (2004). „Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats”. J. Pharmacol. Sci. 94 (3): 246–51. DOI:10.1254/jphs.94.246. PMID 15037809. »WARNING: The reference indicates that zaleplon-Sonata, not zolpidem, increases Slow-wave sleep«
Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T (2004). „Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis”. Human psychopharmacology 19 (5): 305–22. DOI:10.1002/hup.594. PMID 15252823.

espacenet.com

v3.espacenet.com

US patent 4382938, Kaplan J-P, George P, "Imidazo[1,2-a] pyridine derivatives and their application as pharmaceuticals", granted 17. 07. 1984. , assigned to Synthelabo

fda.gov

„FDA Approves First Generic Versions of Ambien (Zolpidem Tartrate) for the Treatment of Insomnia”. Pristupljeno 24. 01. 2010.

gipdatabank.nl

go.com

abcnews.go.com

Childs, Dan (13. 03. 2007.). „Could a Sleeping Pill 'Wake Up' Coma Patients?”. ABC News. Pristupljeno 14. 03. 2007.

guardian.co.uk

Pidd, Helen (12. 09. 2006.). „Reborn”. the Guardian. Pristupljeno 20. 11. 2006.

society.guardian.co.uk

„Judge rejects right-to-die plea by family”. The Guardian. 20. 11. 2006.. Pristupljeno 20. 11. 2006.

jcheminf.com

Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

jneurosci.org

Perrais D, Ropert N (1999). „Effect of zolpidem on miniature IPSCs and occupancy of postsynaptic GABAA receptors in central synapses”. J. Neurosci. 19 (2): 578–88. PMID 9880578.

lww.com

Thomas L. Lemke, David A. Williams, ur. (2002). Foye's Principles of Medicinal Chemistry (5 izd.). Baltimore: Lippincott Willams & Wilkins. str. 376. ISBN 0-7817-4443-1.

mcgraw-hill.com

books.mcgraw-hill.com

Keith Parker; Laurence Brunton; Goodman, Louis Sanford; Lazo, John S.; Gilman, Alfred (2006). Goodman & Gilman's The Pharmacological Basis of Therapeutics (11 izd.). New York: McGraw-Hill. ISBN 0-07-142280-3.

medworksmedia.com

Wang JS, DeVane CL (2003). „Pharmacokinetics and drug interactions of the sedative hypnotics” (PDF). Psychopharmacol Bull 37 (1): 10–29. PMID 14561946. Arhivirano iz originala na datum 2007-07-09. Pristupljeno 2010-10-24.

neurologyreviews.com

Dziedzic J (September 2007). „Minimally conscious patient makes strides following deep brain stimulation”. Neurology Reviews 15 (9). Arhivirano iz originala na datum 2008-06-18. Pristupljeno 2010-10-24.

nih.gov

ncbi.nlm.nih.gov

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
Lemmer B (2007). „The sleep-wake cycle and sleeping pills”. Physiol. Behav. 90 (2-3): 285–93. DOI:10.1016/j.physbeh.2006.09.006. PMID 17049955.
Rosenberg, RP. (Jan 2006). „Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.”. Ann Clin Psychiatry 18 (1): 49–56. DOI:10.1080/10401230500464711. PMID 16517453.
Patat A; Naef MM, van Gessel E, Forster A, Dubruc C, Rosenzweig P (October 1994). „Flumazenil antagonizes the central effects of zolpidem, an imidazopyridine hypnotic”. Clin Pharmacol Ther 56 (4): 430–6. PMID 7955804.
Wesensten NJ; Balkin TJ, Davis HQ, Belenky GL (September 1995). „Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil”. Psychopharmacology (Berl) 121 (2): 242–9. DOI:10.1007/BF02245635. PMID 8545530.
Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G (1986). „Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects”. J. Pharmacol. Exp. Ther. 237 (2): 649–58. PMID 2871178.
Schlich D, L'Heritier C, Coquelin JP, Attali P, Kryrein HJ (1991). „Long-term treatment of insomnia with zolpidem: a multicentre general practitioner study of 107 patients”. J. Int. Med. Res. 19 (3): 271–9. PMID 1670039.
Maarek L, Cramer P, Attali P, Coquelin JP, Morselli PL (1992). „The safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practice”. J. Int. Med. Res. 20 (2): 162–70. PMID 1521672.
Kummer J, Guendel L, Linden J, Eich FX, Attali P, Coquelin JP, Kyrein HJ (1993). „Long-term polysomnographic study of the efficacy and safety of zolpidem in elderly psychiatric in-patients with insomnia”. J. Int. Med. Res. 21 (4): 171–84. PMID 8112475.
Brefel-Courbon C, Payoux P, Ory F, Sommet A, Slaoui T, Raboyeau G, Lemesle B, Puel M, Montastruc JL, Demonet JF, Cardebat D (July 2007). „Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy”. Ann. Neurol. 62 (1): 102–5. DOI:10.1002/ana.21110. PMID 17357126.
Clauss RP, Güldenpfennig WM, Nel HW, Sathekge MM, Venkannagari RR (2000). „Extraordinary arousal from semi-comatose state on zolpidem. A case report”. S. Afr. Med. J. 90 (1): 68–72. PMID 10721397.
Evidente VG, Caviness JN, Adler CH (2003). „Case studies in movement disorders”. Seminars in neurology 23 (3): 277–84. DOI:10.1055/s-2003-814739. PMID 14722823.
Yasui M, Kato A, Kanemasa T, Murata S, Nishitomi K, Koike K, Tai N, Shinohara S, Tokomura M, Horiuchi M, Abe K (2005). „[Pharmacological profiles of benzodiazepinergic hypnotics and correlations with receptor subtypes]” [Pharmacological profiles of benzodiazepinergic hypnotics and correlations with receptor subtypes] (Japanese). Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology 25 (3): 143–51. PMID 16045197.
Uchiumi M, Isawa S, Suzuki M, Murasaki M (August 2000). „The effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance”. Nihon Shinkei Seishin Yakurigaku Zasshi 20 (3): 123–30. PMID 11215153.
Salvà P, Costa J (September 1995). „Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications”. Clin Pharmacokinet 29 (3): 142–53. DOI:10.2165/00003088-199529030-00002. PMID 8521677.
Pritchett DB, Seeburg PH (1990). „Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology”. J. Neurochem. 54 (5): 1802–4. DOI:10.1111/j.1471-4159.1990.tb01237.x. PMID 2157817.
Smith, AJ.; Alder, L.; Silk, J.; Adkins, C.; Fletcher, AE.; Scales, T.; Kerby, J.; Marshall, G. i dr.. (May 2001). „Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux.” (PDF). Mol Pharmacol 59 (5): 1108–18. PMID 11306694.
Rowlett JK, Woolverton WL (November 1996). „Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies”. Psychopharmacology (Berl.) 128 (1): 1–16. DOI:10.1007/s002130050103. PMID 8944400.
Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, Whiting PJ (1996). „Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit”. Mol. Pharmacol. 50 (3): 670–8. PMID 8794909. Arhivirano iz originala na datum 2009-01-08. Pristupljeno 2010-10-24.
Perrais D, Ropert N (1999). „Effect of zolpidem on miniature IPSCs and occupancy of postsynaptic GABAA receptors in central synapses”. J. Neurosci. 19 (2): 578–88. PMID 9880578.
Noguchi H, Kitazumi K, Mori M, Shiba T (2004). „Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats”. J. Pharmacol. Sci. 94 (3): 246–51. DOI:10.1254/jphs.94.246. PMID 15037809. »WARNING: The reference indicates that zaleplon-Sonata, not zolpidem, increases Slow-wave sleep«
Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T (2004). „Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis”. Human psychopharmacology 19 (5): 305–22. DOI:10.1002/hup.594. PMID 15252823.
Hulhoven R, Desager JP, Harvengt C, Hermann P, Guillet P, Thiercelin JF (1988). „Lack of interaction between zolpidem and H2 antagonists, cimetidine and ranitidine”. Int J Clin Pharmacol Res. 8 (6): 471-6. PMID 3253224.
Wang JS, DeVane CL (2003). „Pharmacokinetics and drug interactions of the sedative hypnotics” (PDF). Psychopharmacol Bull 37 (1): 10–29. PMID 14561946. Arhivirano iz originala na datum 2007-07-09. Pristupljeno 2010-10-24.

non-benzodiazepines.org.uk

„Benzodiazepine Names”. Arhivirano iz originala na datum 2008-12-08.

pharmalicensing.com

Pharmalicensing.com Arhivirano 2007-09-03 na Wayback Machine-u, retrieved 20 June 2007.

sanofi-aventis.com

en.sanofi-aventis.com

„sanofi-aventis : Drugs and Products - CNS - Stilnox/Ambien/Myslee”. 07. 11. 2006.. Arhivirano iz originala na datum 2007-09-27. Pristupljeno 22. 11. 2006.

sanofi-aventis.com.au

STILNOX (zolpidem tartrate) PRODUCT INFORMATION Arhivirano 2009-09-13 na Wayback Machine-u Sanofi-Synthelabo Australia Pty Limited. April 15, 2004

sciencedirect.com

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

springer.de

link.springer.de

Rowlett JK, Woolverton WL (November 1996). „Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies”. Psychopharmacology (Berl.) 128 (1): 1–16. DOI:10.1007/s002130050103. PMID 8944400.

web.archive.org

Ambien.com (2004). „AMBIEN Prescribing Information”. Information About a Short-term Treatment for Insomnia - Ambien.com Home Page for Health-care Professionals. Sanofi-Synthelabo Inc. New York, NY 10016. Arhivirano iz originala na datum 2005-06-27. Pristupljeno 27. 06. 2005.
STILNOX (zolpidem tartrate) PRODUCT INFORMATION Arhivirano 2009-09-13 na Wayback Machine-u Sanofi-Synthelabo Australia Pty Limited. April 15, 2004
„sanofi-aventis : Drugs and Products - CNS - Stilnox/Ambien/Myslee”. 07. 11. 2006.. Arhivirano iz originala na datum 2007-09-27. Pristupljeno 22. 11. 2006.
„Benzodiazepine Names”. Arhivirano iz originala na datum 2008-12-08.
Pharmalicensing.com Arhivirano 2007-09-03 na Wayback Machine-u, retrieved 20 June 2007.
Dziedzic J (September 2007). „Minimally conscious patient makes strides following deep brain stimulation”. Neurology Reviews 15 (9). Arhivirano iz originala na datum 2008-06-18. Pristupljeno 2010-10-24.
Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, Whiting PJ (1996). „Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit”. Mol. Pharmacol. 50 (3): 670–8. PMID 8794909. Arhivirano iz originala na datum 2009-01-08. Pristupljeno 2010-10-24.
Wang JS, DeVane CL (2003). „Pharmacokinetics and drug interactions of the sedative hypnotics” (PDF). Psychopharmacol Bull 37 (1): 10–29. PMID 14561946. Arhivirano iz originala na datum 2007-07-09. Pristupljeno 2010-10-24.

wikipedia.org

sh.wikipedia.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit